Instrument/analyser IVDs

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Disponible depuis:

Martin Flynn PTY LTD

classe:

Class 1

Fabriqué par:

DRG International Inc 841 Mountain Avenue, Springfield, NJ, 07081 United States Of America

Domaine thérapeutique:

CT943 - Instrument/analyser IVDs

indications thérapeutiques:

HYB-5252 -GMDN 56718/62413 - The DRG:HYBRiD-XL? was developed for the use in Laboratories, Institutions and Doctors Practices. The DRG:HYBRID-XL? is capable of processing a broad variety of Clinical Chemistry and immunoassay. The DRG:HYBRiD-XL? is a random-access analyzer intended for professional use and must only be used by trained personnel working in compliance with the precautions for use set out in this manual and good laboratory practice (GLP).

Statut de autorisation:

A

Date de l'autorisation:

2020-02-13